Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene for Atrophic Acne Scar Prevention (START)
NCT04856904Phase 4Completed
- Sponsor
- Galderma
- Start
- May 2021
- Primary completion
- Feb 2023
- Countries
- 3
01
Overview
A Phase 4 trial of CD5789 cream vehicle in acne vulgaris, sponsored by Galderma. Started May 2021; status: completed.
02
Drugs
CD5789 cream vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04856904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04856904.